Search hospitals > Ontario > TORONTO
Princess Margaret Cancer Centre
Claim this profileTORONTO, Ontario M5G 2M9
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Prostate Cancer
Conducts research for Solid Tumors
Conducts research for Non-Small Cell Lung Cancer
988 reported clinical trials
68 medical researchers
Summary
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Tumors, Prostate Cancer, Solid Tumors, Non-Small Cell Lung Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 428 conditions. There are 68 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Tumors
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Amit Oza, MDPrincess Margaret Cancer Centre4 years of reported clinical research
Expert in Ovarian Cancer
Studies Ovarian Tumors
27 reported clinical trials
46 drugs studied
Lillian Siu, MDPrincess Margaret Cancer Centre7 years of reported clinical research
Studies Cancer
Studies Breast Cancer
16 reported clinical trials
39 drugs studied
Marcus ButlerPrincess Margaret Cancer Centre7 years of reported clinical research
Studies Melanoma
Studies Bladder Cancer
13 reported clinical trials
24 drugs studied
Philippe BedardPrincess Margaret Cancer Centre2 years of reported clinical research
Studies Tumors
Studies Breast Cancer
14 reported clinical trials
25 drugs studied
Clinical Trials running at Princess Margaret Cancer Centre
Non-Small Cell Lung Cancer
Solid Tumors
Ovarian Cancer
Breast Cancer
Cancer
Multiple Myeloma
Tumors
Lung Cancer
Plasma Cell Neoplasms
Endometrial Cancer
MK-2870
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate sacituzumab tirumotecan versus chemotherapy (docetaxel or pemetrexed) for the treatment of previously-treated non-small cell lung cancer (NSCLC) with exon 19del or exon 21 L858R EGFR mutations (hereafter referred to as EGFR mutations or EGFR-mutated) or any of the follow genomic alterations: ALK gene rearrangements, ROS1 rearrangements, BRAF V600E mutations, NTRK gene fusions, MET exon 14 skipping mutations, RET rearrangements, or less common EGFR point mutations of exon 20 S768I, exon 21 L861Q, or exon 18 G719X mutations. The primary hypotheses are that sacituzumab tirumotecan is: (1) superior to chemotherapy with respect to progression-free survival (PFS) per RECIST 1.1 as assessed by BICR in NSCLC with EGFR mutations; and (2) superior to chemotherapy with respect to overall survival (OS) in NSCLC with EGFR mutations.
Recruiting2 awards Phase 39 criteria
Repotrectinib vs Crizotinib
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).
Recruiting2 awards Phase 36 criteria
Zipalertinib + Chemotherapy
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with locally advanced or metastatic NSCLC with EGFR ex20ins mutations.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Princess Margaret Cancer Centre?
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Tumors, Prostate Cancer, Solid Tumors, Non-Small Cell Lung Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 428 conditions. There are 68 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.
Where is Princess Margaret Cancer Centre located?
**Princess Margaret Cancer Centre Location and Access:**
- **Address:** 610 University Ave, Toronto, ON M5G 2M9.
- **Public Transport:** Accessible via Queen's Park subway station on Line 1, 506 Carlton or 505 Dundas streetcars. The 142 bus provides additional service along University Avenue during rush hours.
- **Drop-off Points:** Murray Street entrance and University Avenue entrance, both wheelchair accessible.
Who should I call to ask about financial aid or insurance network?
The Princess Margaret Cancer Centre offers comprehensive financial assistance and insurance support for patients through various programs:
- **Income Assistance Programs**: Patients can consult a social worker or contact the Psychosocial Oncology clinic at 416-946-4525.
- **Canadian Breast Cancer Support Fund**: Provides up to $1000 for expenses such as transportation, parking, food, home health, prosthetics, supportive care, and rent.
- **Kelly Shires Breast Cancer Foundation**: Offers up to $1000 for similar expenses to those diagnosed with breast cancer.
- **Canadian Cancer Society’s Travel Treatment Fund**: Assists with travel costs based on a financial assessment.
- **Wellspring's Money Matters**: Connects patients with financial counselling for income replacement and drug compensation.
- **Power of Hope Cost Reduction Program**: Aids cancer patients under 40 with fertility preservation treatment costs.
- **POGO Financial Assistance Program**: Supports Ontario families with expenses like accommodation, food, and child care for siblings under 12 during the child's cancer treatment.
- For general inquiries, contact The Princess Margaret Cancer Foundation at 416-946-6560 or toll-free at 1-866-224-6560.
What insurance does Princess Margaret Cancer Centre accept?
The Princess Margaret Cancer Centre accepts Canadian insurance plans, including OHIP and private insurance. OHIP covers most cancer treatment costs, while some expenses might need coverage through private insurance, government programs, or income tax claims. International patients should refer to the UHN International Patient Program (IPP), and private cancer care services may require a referral and can be covered by private insurance or self-pay.
What awards or recognition has Princess Margaret Cancer Centre received?
The Princess Margaret Cancer Centre, located in Toronto, Ontario, is among the top five cancer research centers globally, renowned for its groundbreaking research and exceptional patient care. It boasts a comprehensive clinical trials program, offering numerous trials for different cancer types, with its database frequently updated. The center's innovative work and life-saving research are supported by the Invest in Research program, enhancing its capability to transform patient outcomes worldwide.